This article was originally published in The Tan Sheet
Canadian developer of cholesterol-lowering ingredient Reducol announces four-year licensing and distribution agreement with New York-based Marco Hi-Tech March 26. Forbes has previously handled distribution duties internally. The deal will materially grow the customer base for Forbes, which says Marco Hi-Tech "has the capabilities to penetrate this growing market"...
You may also be interested in...
The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.
With operations in the MENA region already tracking to $700m in revenues for 2020, Hikma is looking to grow the business further after beginning negotiations with GSK to buy certain of the originator’s businesses in Egypt and Tunisia.
A safety study of Pfizer's anchor immunology brand Xeljanz showed higher rates of heart attacks and cancer versus a TNF inhibitor.